Tyra Biosciences Inc Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
2020
2019
0M
-
0M
0M
80M
17M
62M
-80M
0M
-69M
0M
-69M
33.66%
80M
11M
-80M
0M
-80M
0M
-
0M
0M
59M
16M
43M
-59M
0M
-55M
0M
-52M
97.86%
59M
4M
-59M
0M
-59M
0M
-
0M
0M
26M
6M
21M
-26M
0M
-26M
0M
-26M
180.66%
26M
0M
-26M
0M
-26M
0M
-
0M
0M
9M
2M
7M
-9M
0M
-9M
0M
-9M
129.52%
9M
0M
-9M
0M
-9M
0M
-
0M
0M
3M
1M
2M
-3M
0M
-4M
0M
-4M
129.52%
3M
0M
-3M
0M
-3M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
4Q2021
3Q2021
2Q2021
1Q2021
4Q2020
3Q2020
0M
-
0M
0M
26M
5M
21M
-26M
0M
-23M
0M
-23M
-217.12%
26M
3M
-26M
0M
-26M
0M
-
0M
0M
24M
5M
19M
-24M
0M
-21M
0M
-21M
85.98%
24M
3M
-24M
0M
-24M
0M
-
0M
0M
16M
4M
12M
-16M
0M
-13M
0M
-13M
-10.09%
16M
3M
-16M
0M
-16M
0M
-
0M
0M
14M
4M
10M
-14M
2M
-12M
0M
-9M
-36.39%
14M
2M
-14M
0M
-14M
0M
-
0M
0M
15M
5M
10M
-15M
1M
-13M
0M
19M
-296.29%
15M
2M
-15M
0M
-15M
0M
-
0M
0M
14M
3M
11M
-14M
1M
-13M
0M
-11M
71.20%
14M
1M
-14M
0M
-14M
0M
-
0M
0M
15M
3M
12M
-15M
0M
-15M
0M
-15M
167.82%
15M
0M
-15M
0M
-15M
0M
-
0M
0M
15M
5M
10M
-15M
0M
-15M
0M
-15M
252.06%
15M
0M
-15M
0M
-15M
0M
-
0M
0M
10M
3M
7M
-10M
0M
-10M
0M
-10M
169.47%
10M
0M
-10M
0M
-10M
0M
-
0M
0M
7M
1M
5M
-7M
0M
-7M
0M
-7M
184.01%
7M
0M
-7M
0M
-7M
0M
-
0M
0M
6M
1M
4M
-6M
0M
-6M
0M
-6M
184.01%
6M
0M
-5M
0M
-6M
0M
-
0M
0M
4M
1M
4M
-4M
0M
-4M
0M
-4M
184.01%
4M
0M
-4M
0M
-4M
0M
-
0M
0M
4M
1M
3M
-4M
0M
-4M
0M
-4M
184.01%
4M
0M
-4M
0M
-4M
0M
-
0M
0M
2M
0M
2M
-2M
0M
-2M
0M
-2M
184.01%
2M
0M
-2M
0M
-2M